Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EWH BIOPRODUCTION ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   1.0% 0.8% 0.9% 1.0% 1.0% 1.0% 13.5% 11.0%   Credit score (0-100)   87 93 90 86 86 85 16 22   Credit rating   A AA A A A A BB BB   Credit limit (kDKK)   276.8 704.8 750.3 486.0 599.7 251.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,087 5,955 6,538 6,177 6,029 7,029 0.0 0.0   EBITDA   776 2,647 2,190 1,240 1,624 2,859 0.0 0.0   EBIT   692 2,389 1,872 744 1,036 2,330 0.0 0.0   Pre-tax profit (PTP)   644.9 2,320.6 1,843.1 721.0 1,009.7 2,298.1 0.0 0.0   Net earnings   502.5 1,808.2 1,436.0 561.5 786.2 1,791.5 0.0 0.0   Pre-tax profit without non-rec. items   645 2,321 1,843 721 1,010 2,298 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   1,124 1,077 1,337 1,189 961 476 0.0 0.0   Shareholders equity total   3,109 4,418 5,354 5,415 5,701 1,993 868 868   Interest-bearing liabilities   220 191 782 13.6 268 264 0.0 0.0   Balance sheet total (assets)   4,907 6,361 8,356 8,040 7,890 4,337 868 868   Net Debt   -1,887 -2,869 -4,455 -4,677 -4,931 -1,181 -868 -868     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,087 5,955 6,538 6,177 6,029 7,029 0.0 0.0   Gross profit growth   11.7% 17.1% 9.8% -5.5% -2.4% 16.6% -100.0% 0.0%   Employees   0 0 9 10 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 6.7% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,907 6,361 8,356 8,040 7,890 4,337 868 868   Balance sheet change%   12.8% 29.6% 31.4% -3.8% -1.9% -45.0% -80.0% 0.0%   Added value   692.3 2,389.4 1,872.1 744.0 1,036.1 2,330.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   803 -304 -59 -645 -815 -1,014 -476 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.6% 40.1% 28.6% 12.0% 17.2% 33.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.0% 42.4% 25.5% 9.2% 13.0% 38.1% 0.0% 0.0%   ROI %   20.7% 59.4% 34.6% 12.6% 17.7% 56.7% 0.0% 0.0%   ROE %   16.2% 48.0% 29.4% 10.4% 14.1% 46.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   63.4% 69.5% 64.1% 67.4% 72.3% 45.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -243.1% -108.4% -203.4% -377.1% -303.6% -41.3% 0.0% 0.0%   Gearing %   7.1% 4.3% 14.6% 0.3% 4.7% 13.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   23.0% 33.5% 7.5% 7.7% 20.6% 12.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   2.2 3.5 2.6 3.0 3.4 1.9 0.0 0.0   Current Ratio   2.3 3.7 2.7 3.1 3.5 2.0 0.0 0.0   Cash and cash equivalent   2,106.6 3,059.9 5,236.3 4,690.6 5,199.8 1,445.2 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,123.2 3,700.1 4,293.5 4,525.6 4,812.8 1,879.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 208 77 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 243 129 0 0 0 0   EBIT / employee   0 0 208 77 0 0 0 0   Net earnings / employee   0 0 160 58 0 0 0 0